98 related articles for article (PubMed ID: 20529093)
1. Peripheral antinociceptive effect of 2-arachidonoyl-glycerol and its interaction with endomorphin-1 in arthritic rat ankle joints.
Mecs L; Tuboly G; Toth K; Nagy E; Nyari T; Benedek G; Horvath G
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):544-50. PubMed ID: 20529093
[TBL] [Abstract][Full Text] [Related]
2. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
3. The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level.
Petrovszki Z; Kovacs G; Tömböly C; Benedek G; Horvath G
Anesth Analg; 2012 Jun; 114(6):1346-52. PubMed ID: 22451592
[TBL] [Abstract][Full Text] [Related]
4. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Guindon J; Desroches J; Beaulieu P
Br J Pharmacol; 2007 Mar; 150(6):693-701. PubMed ID: 17179944
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level.
Tuboly G; Mecs L; Benedek G; Horvath G
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):400-5. PubMed ID: 19018802
[TBL] [Abstract][Full Text] [Related]
6. The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats.
Horvath G; Joo G; Dobos I; Klimscha W; Toth G; Benedek G
Anesth Analg; 2001 Oct; 93(4):1018-24. PubMed ID: 11574376
[TBL] [Abstract][Full Text] [Related]
7. Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception.
Li Z; Proud D; Zhang C; Wiehler S; McDougall JJ
Arthritis Rheum; 2005 Oct; 52(10):3210-9. PubMed ID: 16200625
[TBL] [Abstract][Full Text] [Related]
8. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
[TBL] [Abstract][Full Text] [Related]
9. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
10. Endomorphin 1[psi] and endomorphin 2[psi], endomorphins analogues containing a reduced (CH2NH) amide bond between Tyr1 and Pro2, display partial agonist potency but significant antinociception.
Zhao QY; Chen Q; Yang DJ; Feng Y; Long Y; Wang P; Wang R
Life Sci; 2005 Jul; 77(10):1155-65. PubMed ID: 15878600
[TBL] [Abstract][Full Text] [Related]
11. The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level.
Farkas I; Tuboly G; Benedek G; Horvath G
Pharmacol Biochem Behav; 2011 Oct; 99(4):731-7. PubMed ID: 21624393
[TBL] [Abstract][Full Text] [Related]
12. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
13. The antinociceptive potencies and interactions of endogenous ligands during continuous intrathecal administration: adenosine, agmatine, and endomorphin-1.
Kekesi G; Dobos I; Benedek G; Horvath G
Anesth Analg; 2004 Feb; 98(2):420-426. PubMed ID: 14742381
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effect of continuous intrathecal administration of endomorphin-1.
Csullog E; Joo G; Toth G; Dobos I; Benedek G; Horvath G
Pain; 2001 Oct; 94(1):31-38. PubMed ID: 11576742
[TBL] [Abstract][Full Text] [Related]
15. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain.
Guindon J; De Léan A; Beaulieu P
Pain; 2006 Mar; 121(1-2):85-93. PubMed ID: 16480822
[TBL] [Abstract][Full Text] [Related]
16. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
17. Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence.
Aguiar DD; Gonzaga ACR; Teófilo ALH; Miranda FA; Perez AC; Duarte IDG; Romero TRL
Life Sci; 2022 Mar; 293():120279. PubMed ID: 35032552
[TBL] [Abstract][Full Text] [Related]
18. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
20. Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain.
Khasabova IA; Chandiramani A; Harding-Rose C; Simone DA; Seybold VS
Pharmacol Res; 2011 Jul; 64(1):60-7. PubMed ID: 21440630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
